ClinConnect ClinConnect Logo
Search / Trial NCT06528379

Physical Activity Component of the Greek Interventional Geriatric Study to Prevent Cognitive Impairment and Disability (GINGER)

Launched by UNIVERSITY OF PATRAS · Jul 29, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

The GINGER study is a research trial designed to explore whether a special physical activity program can help improve memory, physical abilities, and overall quality of life for people who feel they may be experiencing early signs of cognitive decline, known as Subjective Cognitive Impairment (SCI). This six-month program is taking place in multiple centers in Greece and is open to individuals aged 18 and older. To participate, candidates must have a score above 7 on a specific questionnaire that indicates cognitive decline but should not have any diagnosed cognitive impairments, such as Mild Cognitive Impairment or dementia.

Participants in the study will engage in tailored exercise routines aimed at boosting their mental and physical health. The program not only focuses on physical activity but also on how these exercises can enhance well-being and daily living. It's important to note that individuals with certain medical conditions, recent surgeries, or those who cannot communicate in Greek cannot take part in this study. If you or someone you know is interested and meets the eligibility criteria, this could be a valuable opportunity to contribute to important research while also potentially benefiting from the exercise program.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria include people with:
  • Subjective Cognitive Decline confirmed from the Subjctive Cognitive Decline Questionnaire (SCD - Q score \>7)
  • Absence of objective cognitive imparement as confirmed from cognitive assessment tests (i.e. MoCA, Trail A \& B, Stroop, RCFT, FAS. )
  • Exclusion Criteri include people with:
  • Mild Cognitive Impairement (MCI) or dementia
  • Chronic psychiatric or neurological disorders affecting cognition (i.e. bipolar disorder, schizophrenia, MS, TBI, Parkinson's disease etc.)
  • Unstable pathological diseases (i.e. uncontrolled hypothyrodism, athythmias, uncontrolled hypertension, high blood pressure at rest etc.)
  • Recent (\<6 month) surgery, which restrics active participation in exercise/physical activity
  • inadequate knowledge of Greek

About University Of Patras

The University of Patras, a leading academic institution in Greece, is dedicated to advancing medical research and clinical trials that contribute to the understanding and treatment of various health conditions. With a strong emphasis on interdisciplinary collaboration, the university leverages its cutting-edge facilities and expert faculty to conduct innovative clinical studies. The institution is committed to upholding the highest ethical standards and regulatory compliance, ensuring the safety and well-being of participants while striving to enhance patient care through scientific discovery and translation of research findings into clinical practice.

Locations

Patra, Achaia, Greece

Patra, , Greece

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported